Quest Diagnostics Incorporated (NYSE:DGX) has tumbled 2.22% during the past week and has dropped 1.03% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 1.05%. Quest Diagnostics Incorporated (NYSE:DGX) has underperformed the index by 1.94% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
Quest Diagnostics Incorporated (NYSE:DGX): The stock opened at $77.13 on Friday but the bulls could not build on the opening and the stock topped out at $77.27 for the day. The stock traded down to $75.20 during the day, due to lack of any buying support eventually closed down at $75.73 with a loss of -1.78% for the day. The stock had closed at $77.10 on the previous day. The total traded volume was 1,953,876 shares.
The company shares have rallied 3.26% from its 1 Year high price. On Jun 9, 2016, the shares registered one year high at $78.97 and the one year low was seen on Feb 9, 2016. The 50-Day Moving Average price is $76.66 and the 200 Day Moving Average price is recorded at $70.86.
On the companys insider trading activities, Doherty Catherine T., officer (SVP, Clin. Franchise Solutions) of Quest Diagnostics Inc, unloaded 47,334 shares at an average price of $77.27 on May 27, 2016. The total amount of the transaction was worth $3,657,498, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Many analysts have stated their opinion on the company shares. Credit Suisse initiates coverage on Quest Diagnostics Incorporated (NYSE:DGX) The current rating of the shares is Neutral. Equity Analysts at the Firm announces the price target to $72 per share. The rating by the firm was issued on March 15, 2016. Currently the company Insiders own 1.5% of Quest Diagnostics Incorporated shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -7.12% . Institutional Investors own 93.51% of Quest Diagnostics Incorporated shares. During last six month period, the net percent change held by insiders has seen a change of -7.27%.
Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.